CRISPR Therapeutics’ Lundberg Steps Down as Chief Scientific Officer – Xconomy
GlobeNewswire (press release) |
CRISPR Therapeutics' Lundberg Steps Down as Chief Scientific Officer
Xconomy Bill Lundberg is leaving his position as chief scientific officer of CRISPR Therapeutics (NASDAQ: CRSP). CRISPR Therapeutics, which has operations in Switzerland and Cambridge, MA, said that Lundberg will continue as an advisor to the company and he is … CRISPR Therapeutics Announces Transition of Bill Lundberg, MD Why Crispr Therapeutics AG Stock Bolted Higher in January What's CRISPR Therapeutics AG (CRSP) Upside After Today's Big Increase? |
